Ventlator-associated pneumonia (VAP) is a hospital-acquired infecton that afects 15-20% of the 3 million ventlated patents in the United States annually. VAP is associated with mortality of 30% and significant morbidity - including extended Medical Intensive Care Unit (MICU) and hospital stays. However, clinical studies on patent recumbency have shown that recumbency at 30-45% is associated with significant reducton in VAP. To tackle this issue, Perry Dubin, MD, MPH created Angulus. Angulus is a small 1”x2” biosensor that afxes via silicone adhesive directly to the chest of a patent. It contains a disposable inclinometer that digitally measures patent recumbency and has the ability to wirelessly transmit informaton to electronic health records and display data on vital sign and telemetry monitors.
Proposed Healthcare Solution
Disposable inclinometer that affixes to the patient sternum to measure patient recumbency and transmit to EHR, displaying data on vital sign and telemetry monitors, to reduce ventilator-associated pneumonia (VAP)
Licensed to Industry
Perry Dubin, MD, MPH